The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 08, 2022
Filed:
Nov. 15, 2018
Applicant:
Amgen Inc., Thousand Oaks, CA (US);
Inventors:
Alona Teran, Moorpark, CA (US);
William Callahan, Thousand Oaks, CA (US);
Qahera Munaim, Chatsworth, CA (US);
Rahul Kaushik, Thousand Oaks, CA (US);
Assignee:
AMGEN INC., Thousand Oaks, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/60 (2017.01); A61K 38/07 (2006.01); A61K 47/26 (2006.01); A61P 35/00 (2006.01); A61K 47/02 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 9/19 (2006.01); A61K 47/42 (2017.01); A61K 47/12 (2006.01); A61K 9/08 (2006.01);
U.S. Cl.
CPC ...
A61K 47/60 (2017.08); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 38/07 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61P 35/00 (2018.01);
Abstract
The present invention provides stable pharmaceutical compositions of pegylated carfilzomib compounds, methods for preparing the compositions, and uses of the compositions for treating cancer, including hematologic malignancies such as multiple myeloma. The compositions can be stored in frozen form or lyophilized to dry solid form.